ChristineHelene(Adolff-Holschneider)HolschneiderMD

Obstetrics & Gynecology • Sylmar, CA

Gynecologic Oncology

Associate Professor, Obstetrics & Gynecology, University of California Los Angeles David Geffen SOM

Join to view full profile

Are you Dr. Holschneider?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

Connect with colleagues in the same hospital or clinic
You already have 36 invites waiting!
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

Claim this profile

Not you? Find your profile

Office
14445 Olive View Dr Rm 2b-163
Department Of Ob-Gyn
Sylmar, CA 91342
Phone+1 818-364-3222

Fax+1 818-364-3255
Is this information wrong?

Summary

Dr. Christine (Adolff-Holschneider) Holschneider, MD is an obstetrician/gynecologist in Sylmar, California. She is currently licensed to practice medicine in California. She is affiliated with Olive View-UCLA Medical Center and is an Associate Professor at University of California Los Angeles David Geffen SOM.

Education & Training

UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Obstetrics and Gynecology, 1994 - 1998
Freie University Berlin Faculty of MedicineClass of 1988

Certifications & Licensure

CA State Medical License 1995 - 2025
American Board of Obstetrics and Gynecology Obstetrics & Gynecology
American Board of Obstetrics and Gynecology Gynecologic Oncology

Awards, Honors, & Recognition

Fellow (FACOG) American Congress of Obstetricians and Gynecologists

Clinical Trials

Comparison of Screening Tests in Detecting Cervical Neoplasia Start of enrollment: 1999 Dec 01
Completed
Not Applicable
Radiation Therapy With or Without Cisplatin in Treating Patients With Recurrent Endometrial Cancer Start of enrollment: 2008 Feb 25
Active, not recruiting
Phase 2
Diet and Physical Activity Change or Usual Care in Improving Progression-Free Survival in Patients With Previously Treated Stage II, III, or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Start of enrollment: 2012 Jun 18
Recruiting
Phase 3
Paclitaxel and Cisplatin or Topotecan With or Without Bevacizumab in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer Start of enrollment: 2009 Apr 01
Completed
Phase 3
Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II Endometrial Cancer Start of enrollment: 2009 Mar 23
Active, not recruiting
Phase 3
CA-IX, p16, Proliferative Markers, and HPV in Diagnosing Cervical Lesions in Patients With Abnormal Cervical Cells Start of enrollment: 2009 Feb 09
Active, not recruiting
Not Applicable
Collecting Tumor Samples From Patients With Gynecological Tumors Start of enrollment: 1992 Jun 01
Completed
Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed, Persistent or Recurrent Uterine, Ovarian, Fallopian Tube, or Peritoneal Cavity Cancer Start of enrollment: 2009 Aug 17
Active, not recruiting
Phase 3
Lymphedema After Surgery in Patients With Endometrial Cancer, Cervical Cancer, or Vulvar Cancer Start of enrollment: 2012 Jun 01
Unknown status
Not Applicable
Gemcitabine Hydrochloride and Docetaxel With or Without Bevacizumab in Treating Patients With Advanced or Recurrent Uterine Leiomyosarcoma Start of enrollment: 2009 Nov 01
Terminated
Phase 3
Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal Tumors Start of enrollment: 2010 Feb 08
Active, not recruiting
Phase 2
Carboplatin and Paclitaxel or Oxaliplatin and Capecitabine With or Without Bevacizumab as First-Line Therapy in Treating Patients With Newly Diagnosed Stage II-IV or Recurrent Stage I Epithelial Ovarian or Fallopian Tube Cancer Start of enrollment: 2010 Oct 12
Active, not recruiting
Phase 3
Radiation Therapy With or Without Chemotherapy in Patients With Stage I-IIA Cervical Cancer Who Previously Underwent Surgery Start of enrollment: 2010 Apr 12
Active, not recruiting
Phase 3
Cisplatin and Radiation Therapy With or Without Carboplatin and Paclitaxel in Patients With Locally Advanced Cervical Cancer Start of enrollment: 2012 Jan 09
Completed
Phase 3
Studying the Physical Function and Quality of Life Before and After Surgery in Patients With Stage I Cervical Cancer Start of enrollment: 2012 Oct 01
Active, not recruiting
Not Applicable
Paclitaxel and Carboplatin With or Without Metformin Hydrochloride in Treating Patients With Stage III, IV, or Recurrent Endometrial Cancer Start of enrollment: 2014 Mar 17
Active, not recruiting
Phase 2, Phase 3
Join now to see all

Publications & Presentations

PubMed

The Role of Preoperative Antibiotics in Surgical Site Infection (SSI) Rate after Class I/Clean Gynaecologic Surgery at an Academic Safety Net Hospital.
Khalfay, N., Markovic, D., Holschneider, C., Dejbakhsh, S., Escher, K., Han, M.> ;Journal of Obstetrics and Gynaecology Canada. 2024 Feb 8
Integrating social care into gynecologic oncology: Identifying and addressing patient's social needs.
Katherine Cotangco, Elizabeth Pineda, Veda Hingarh, Natsai C Nyakudarika, Joshua G Cohen, Christine H Holschneider> ;Gynecologic Oncology. 2023 Dec 1
23 citations
Adjuvant chemotherapy following chemoradiotherapy as primary treatment for locally advanced cervical cancer versus chemoradiotherapy alone (OUTBACK): an international,...
Linda R Mileshkin, Kathleen N Moore, Elizabeth H Barnes, Val Gebski, Kailash Narayan, Madeleine T King, Nathan Bradshaw, Yeh Chen Lee, Katrina Diamante, Anthony W Fyle...> ;The Lancet. Oncology. 2023 May 1
4 citations
Universal social needs assessment in gynecologic oncology: An important step toward more informed and targeted care in the public safety net
Natsai C. Nyakudarika, Christine H. Holschneider, Abdulrahman K. Sinno> ;Cancer. 2021 Oct 15
4 citations
Prioritizing Surgical Services during on-Going Pandemic Response: Modification and Reliability of the Medically Necessary Time Sensitive Surgery (MeNTS) Scoring Tool.
Erin Saleeby, Cecilia K. Wieslander, Christina Truong, Lisa Marie Garcia, Sarah Eckhardt, A. Hari, Laila Al-Marayati, Lisa Greenwell, Christine H. Holschneider> ;Journal of Medical Systems. 2021 Apr 7
1 citations
The role of the genetic testing industry in patient education of hereditary cancer: An observational study assessing the quality of patient education videos.
Danielle Collins Greenberg, Daniella Kamara, Zina Tatsugawa, Marlene Mendoza, E. Pineda, Christine H. Holschneider, Mae Zakhour> ;Gynecologic Oncology. 2020 Nov 1
16 citations
The ASTRO clinical practice guidelines in cervical cancer: Optimizing radiation therapy for improved outcomes.
Junzo Chino, Christina M. Annunziata, Sushil Beriwal, Lisa Bradfield, Beth Erickson, Emma C. Fields, Jane Fitch, Matthew M. Harkenrider, Christine H. Holschneider, Mit...> ;Gynecologic Oncology. 2020 Sep 22
8 citations
Socially determined cervical cancer care navigation: An effective step toward health care equity and care optimization.
Kimberly Dessources, A. Hari, E. Pineda, Malaika W. Amneus, Abdulrahman K. Sinno, Christine H. Holschneider> ;Cancer. 2020 Dec 1
3 citations
Managing opioid use in the acute surgical setting: A society of gynecologic oncology clinical practice statement.
Christine H. Kim, Carolyn Lefkowits, Christine H. Holschneider, Kristin Bixel, Bhavana Pothuri> ;Gynecologic Oncology. 2020 Jun 1
3 citations
Success of an EMR-Driven Postpartum Intervention to Improve HPV Vaccination Rates.
Susan K Park, Christine H. Holschneider, Judy Y. Chen, Erin Saleeby, Rita Singhal> ;Journal of Community Health. 2020 Jun 1
78 citations
Radiation Therapy for Cervical Cancer: Executive Summary of an ASTRO Clinical Practice Guideline.
Junzo Chino, Christina M Annunziata, Sushil Beriwal, Lisa Bradfield, Beth A Erickson, Emma C Fields, KathrynJane Fitch, Matthew M Harkenrider, Christine H Holschneider...> ;Practical Radiation Oncology. 2020 May 18
7 citations
Prognostic role of pathologic response and cytoreductive status at interval debulking surgery after neoadjuvant chemotherapy for advanced epithelial ovarian cancer
Margaret I. Liang, E.N. Prendergast, Jeanine N. Staples, Christine H. Holschneider, Joshua G. Cohen, Ilana Cass> ;Journal of Surgical Oncology. 2019 Jul 8
41 citations
Brachytherapy: A critical component of primary radiation therapy for cervical cancer: From the Society of Gynecologic Oncology (SGO) and the American Brachytherapy Soc...
Christine H. Holschneider, Daniel G. Petereit, Christina Chu, I-Chow Hsu, Yevgeniya Ioffe, Ann H. Klopp, Bhavana Pothuri, Lee-may Chen, Catheryn M. Yashar> ;Gynecologic Oncology. 2019 Mar 1
60 citations
Brachytherapy: A critical component of primary radiation therapy for cervical cancer: From the Society of Gynecologic Oncology (SGO) and the American Brachytherapy Soc...
Christine H. Holschneider, Daniel G. Petereit, Christina Chu, I-Chow Hsu, Yevgeniya Ioffe, Ann H. Klopp, Bhavana Pothuri, Lee-may Chen, Catheryn M. Yashar> ;Brachytherapy. 2019 Mar 1
3 citations
Effectiveness of Assessing Ureteral Patency Using Preoperative Phenazopyridine.
Elizabeth M. Strom, Zaid Chaudhry, Rong Guo, Axeline J. Maisonet, Christine H. Holschneider, Cecilia K. Wieslander> ;Female Pelvic Medicine & Reconstructive Surgery. 2018 Jan 1
29 citations
Vulvar intraepithelial neoplasia: Risk factors for recurrence
W. Satmary, Christine H. Holschneider, Laurie L. Brunette, Sathima Natarajan> ;Gynecologic Oncology. 2018 Jan 1
4 citations
Use of a Hospital-Wide Screening Program for Early Detection of Sepsis in General Surgery Patients.
Ian T. MacQueen, Aaron J. Dawes, Tracy N. Hadnott, Kristen Strength, Gregory J. Moran, Christine H. Holschneider, Marcia M. Russell, Melinda Maggard-Gibbons> ;The American Surgeon. 2015 Oct 1
4 citations
Gestational Trophoblastic Disease Diagnosis Delayed by the Hook Effect.
Julia Cormano, Gillian Mackay, Christine H. Holschneider> ;Obstetrics and Gynecology. 2015 Oct 1
12 citations
Almost half of women with endometrial cancer or hyperplasia do not know that obesity affects their cancer risk
Anna Beavis, Simrin Cheema, Christine H. Holschneider, Erin Lindsey Duffy, Malaika W. Amneus> ;Gynecologic Oncology Reports. 2015 Aug 1
3 citations
Paradigm shifts: using a participatory leadership process to redesign health systems.
Erin Saleeby, Christine H. Holschneider, Rita Singhal> ;Current Opinion in Obstetrics & Gynecology. 2014 Dec 1
31 citations
Predictors of residual carcinoma or carcinoma-in-situ at hysterectomy following cervical conization with positive margins
Elena S. Diaz, Chisa Aoyama, Mary Anne Baquing, Anna Beavis, Elvio G. Silva, Christine H. Holschneider, Ilana Cass> ;Gynecologic Oncology. 2014 Jan 1
10 citations
Tattoo pigment lymphadenopathy mimicking metastasis in vulvar cancer.
Anna Beavis, Malaika W. Amneus, Chisa Aoyama, Christine H. Holschneider> ;Obstetrics and Gynecology. 2012 Aug 1
40 citations
Predictors of resolution of complex atypical hyperplasia or grade 1 endometrial adenocarcinoma in premenopausal women treated with progestin therapy.
Kristine R. Penner, Oliver Dorigo, Chisa Aoyama, Nora Ostrzega, Bonnie Balzer, Jianyu Rao, Christine Walsh, Ilana Cass, Christine H. Holschneider> ;Gynecologic Oncology. 2012 Mar 1
252 citations
Posttreatment surveillance and diagnosis of recurrence in women with gynecologic malignancies: Society of Gynecologic Oncologists recommendations
Ritu Salani, Floor J. Backes, Michael Fung Kee Fung, Christine H. Holschneider, Lynn P. Parker, Robert E. Bristow, Barbara A. Goff> ;American Journal of Obstetrics and Gynecology. 2011 Jun 1
179 citations
Identification of patient groups at highest risk from traditional approach to ovarian cancer treatment
Giovanni Aletti, Eric L. Eisenhauer, Antonio Santillan, Allison E. Axtell, Giacomo Aletti, Christine H. Holschneider, Dennis S. Chi, Robert E. Bristow, William A. Cliby> ;Gynecologic Oncology. 2011 Jan 1
Join now to see all

Professional Memberships

American College of Obstetricians and Gynecologists
Fellow

Hospital Affiliations

Olive View-UCLA Medical CenterSylmar, California